Open-label, PK and Safety Study in Mild-to-moderate Alzheimer's Disease Patients

Condition:   Alzheimer Disease Intervention:   Drug: PTI-125 Sponsors:   Pain Therapeutics;   National Institutes of Health (NIH) Recruiting

Source: ClinicalTrials.gov - November 21, 2018 Category: Research Source Type: clinical trials